The post “A Godsend”: ProPublica’s Rx Inspector Tool Is Helping People Find Critical Safety Information on Generic Drugs ...

The post ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs appeared first on ProPublica.

Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

Every January, pharmaceutical companies increase the prices of hundreds of drugs. This year there's a disconnect between the ...

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...

Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...

The US Supreme Court will hear generic drug maker Hikma Pharmaceuticals USA Inc.'s challenge of an appeals court holding that ...

Investigation raises concerns about lack of FDA quality testing for generic drugs By some estimates, about 90% of prescriptions in the U.S. are filled with generic drugs. The Food and Drug ...

By Rishika Sadam and Kashish Tandon Jan 23 (Reuters) - Indian drugmakers Sun Pharmaceutical Industries, Zydus Lifesciences ...

Generic drugs are cheaper copies of brand drugs, offering significant savings to patients. Once a brand-name drug's patent expires, competitors can apply to make generic versions. Generic ...

The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...

The Trump administration isn't planning to impose tariffs on generic drug imports, The Wall Street Journal reported, although the move isn't final and could change in the coming weeks. "The ...